Toxicities Prior to Starting Enzyme Throughout 2 Years on Therapy [clinicaltrials_resource:5d6ca251d4101deb106752d0bfb058bb]
Adverse events that occur after administration with Laronidase.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Toxicities Prior to Starting Enzyme Throughout 2 Years on Therapy [clinicaltrials_resource:5d6ca251d4101deb106752d0bfb058bb]
Adverse events that occur after administration with Laronidase.
Bio2RDF identifier
5d6ca251d4101deb106752d0bfb058bb
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5d6ca251d4101deb106752d0bfb058bb
measure [clinicaltrials_vocabulary:measure]
Toxicities
time frame [clinicaltrials_vocabulary:time-frame]
Prior to Starting Enzyme Throughout 2 Years on Therapy
description
Adverse events that occur after administration with Laronidase.
identifier
clinicaltrials_resource:5d6ca251d4101deb106752d0bfb058bb
title
Toxicities Prior to Starting Enzyme Throughout 2 Years on Therapy
@en
type
label
Toxicities Prior to Starting E ...... ca251d4101deb106752d0bfb058bb]
@en